Navigation Links
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
Date:2/13/2008

39.9 million, compared to $37.1 million in the prior year, an increase of 8% that resulted primarily from European market development efforts.

General and administrative (G&A) expenses in the fourth quarter of 2007 were $12.3 million, compared to $10.8 million in the prior year period, an increase of 14% that resulted primarily from increased compensation costs. For the full year 2007, G&A expenses were $47.0 million, compared to $44.9 million in the prior year, an increase of 5%.

Gen-Probe continues to have a strong balance sheet. As of December 31, 2007, the Company had $433.5 million of cash, cash equivalents and short-term investments, and no debt. In 2007, Gen-Probe generated net cash of $109.6 million from its operating activities, higher than the Company's net income of $86.1 million.

Initial 2008 Financial Guidance

"We expect 2008 to be another year of double-digit revenue growth and high profitability for Gen-Probe, even as we continue to invest in attractive R&D projects to drive our long-term prospects," said Herm Rosenman, the Company's senior vice president of finance and chief financial officer. "Although we expect our tax rate to increase to a normalized level in 2008, our guidance anticipates pre-tax income growing at its fastest pace since 2004."

For the full year 2008, Gen-Probe expects the following on a GAAP basis:

-- Total revenues of $443 million to $453 million, representing growth of

10% to 12% over 2007. Product sales growth is expected to be led by

continued market share gains for the APTIMA Combo 2 assay, by

commercial pricing of the PROCLEIX WNV assay on the TIGRIS system in

the United States, and by ongoing international expansion of the

PROCLEIX ULTRIO assay on the TIGRIS system. Although Gen-Probe

believes the US Food and Drug Administration (FDA) will approve a

hepatitis B "screening claim" for the PROCLEIX ULTRIO a
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Carl Hull Named President and Chief Operating Officer of Gen-Probe
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
5. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
6. Imagenetix Inc. Reports Third Fiscal Quarter Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...Belfast is to become the United Kingdom,s lead cen...ious ,cyber-attacks, after a funding boost from th...il. , Almost 7m from the EPSRC will help fund a...for Secure Information Technologies (CSIT) - which..., Communications and Information Technology (ECIT)...
(Date:11/20/2008)... Nov. 20 Par Pharmaceuti... that the U.S. District Court for the District of ...uticals, motion for a temporary restraining order ...spules(R) (budesonide inhaled solution). In conju...eneca agreed and that it too would halt all sales ...
(Date:11/20/2008)...RNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: S...ON(R) In VIVO QUALITY and iScale,Oligos(TM) siRNA... siRNA are,expected to allow researchers to succe... with the highest purity and quality siRNA require... are believed to be well suited to target,validat...
(Date:11/20/2008)... KansasBio announced today a,bios...e region,s human,health-care-related bioscience c...ontinuum. Called the National Drug Development Acc...s companies across Kansas and the Kansas,City met... preferred resources,for drug development. , ...
Breaking Biology Technology:Queen's 'secures' £25m for UK's cyber-safety 2Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models 2National Drug Development Accelerator Launched 2
... and CEO of ZyStor Therapeutics, Inc. is looking...ttendees of this year,s Midwestern bioscience foru...ill represent Wisconsin biotechnology companies wi...Madison-based EraGen Biosciences , a developer of...e attendees, Peterson is interested in the network...
...tartup biotechnology firm with laboratories in Mil...the gap between molecular and animal testing metho...disorders, and other maladies, Invivo,s manufactur... ,Using tissues derived from neonatal rats, the co...nsin Biotechnology and Medical Device Association ...
...consin research team has received a five-year, $1... pressure. , ,The grant was provided by the Natio...the impact that genes within specific regions of c...ssure and kidney failure. According to the institu...n, affects one in three American adults. , ,The Me...
... University of Wisconsin-Madison stimulates the l...anies. But a new study has produced figures to bac...sed in the University Research Park , located thr...ased on university research. And the concentration..., has had a significant impact on the surrounding ...
Other Biology Technology:ZyStor to exhibit cell disorder treatments 2Biotech firm uses live heart tissue in drug screens 2Biotech firm uses live heart tissue in drug screens 3Medical College receives $11 million grant to study high blood pressure 2Impact of research park firms pegged at $680M 2
(Date:11/21/2008)...rdiovascular conditions leading to heart attacks a...n cancers of the prostate, breast or lung, but now...hanisms at the molecular level. This in turn provi...cer and cardiovascular diseases, but requires rese... The seeds were sown for closer cooperation betwee...
(Date:11/20/2008)...SHINGTON, DC Although Americans are becoming incr...ryday household products like bisphenol A in some ...eadily connect typical household products with per... effects, according to research from the December ...r . , "People more readily equate pollution wit...
(Date:11/20/2008)...TTSBURGHResearch from the University of Pittsburgh...uld finally provide evidence of the first stages o...olds that males and females developed from hermaph...letely understood because the majority of animal s...g separate-sex state too long ago for scientists t...
(Date:11/20/2008)...his release is available in German . , Hal... get a comprehensive overview of which alien speci...uences for the environment and society. More than ...E (Delivering Alien Invasive Species Inventory for...h more than 100 European scientists, funded by the...
Breaking Biology News(10 mins):Mechanisms of cardiovascular disease and cancer give clues to new therapies 2Mechanisms of cardiovascular disease and cancer give clues to new therapies 3Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters 2Two from one: Pitt research maps out evolution of genders from hermaphroditic ancestors 211,000 alien species invade Europe 2NIH funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors 13533 1NIH funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors 13533 2Cultivating the Smart Patient 3A Author and RealAge Founder Michael F Roizen MD to Present Keynote at URAC Conference 13528 1Cultivating the Smart Patient 3A Author and RealAge Founder Michael F Roizen MD to Present Keynote at URAC Conference 13528 2Cultivating the Smart Patient 3A Author and RealAge Founder Michael F Roizen MD to Present Keynote at URAC Conference 13528 3Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 1Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 2Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 3Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 4New Books on Best Practices in Biotechnology Business Development and Biotechnology Education 3730 1New Books on Best Practices in Biotechnology Business Development and Biotechnology Education 3730 2
...s of directional cues to guide their seasonal migr...h,s magnetic field, and sky polarized light patter...ty changes with time of day and weather conditions...common reference. Experiments over the last 30 yea... of how migratory birds integrate multiple sources...
...en,s Research Hospital have announced that a vacci...genic variant of the avian influenza virus H5N1 ma...rus. Vaccines based on this model might therefore ...mic (worldwide epidemic) until a new vaccine could...sing the outbreak, the researchers said. An antige...
... last several months, the labs of Yale Goldman, MD...te at the University of Pennsylvania School of Med...ology, have published a group of papers that, take...ar motors are surprisingly flexible and agile, abl...ervations could lead to better ways to treat motor...
...lifetime of daily injections to replace the insuli...of risks that includes blindness, amputation, kidn...rly those afflicted with juvenile diabetes, transp... produced might alleviate these problems. Unfortun...ailable for transplantation. , Insulin-producing p...
Other Biology News:Light guides flight of migratory birds 2Light guides flight of migratory birds 3H5N1 vaccine could be basis for life-saving stockpile 2Discovery of agile molecular motors could aid in treating motor neuron diseases 2Successful transplantation from pig embryos to mice 2